EA
Emerald Advisers’s Haemonetics HAE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-66,108
| Closed | -$5.47M | – | 256 |
|
|
2024
Q2 | $5.47M | Sell |
66,108
-64,329
| -49% | -$5.32M | 0.23% | 111 |
|
|
2024
Q1 | $11.1M | Sell |
130,437
-16,877
| -11% | -$1.44M | 0.45% | 90 |
|
|
2023
Q4 | $12.6M | Sell |
147,314
-4,149
| -3% | -$355K | 0.54% | 78 |
|
|
2023
Q3 | $13.6M | Sell |
151,463
-23,387
| -13% | -$2.1M | 0.66% | 70 |
|
|
2023
Q2 | $14.9M | Buy |
174,850
+371
| +0.2% | +$31.6K | 0.65% | 71 |
|
|
2023
Q1 | $14.4M | Sell |
174,479
-1,695
| -1% | -$140K | 0.69% | 68 |
|
|
2022
Q4 | $13.9M | Sell |
176,174
-145,097
| -45% | -$11.4M | 0.67% | 69 |
|
|
2022
Q3 | $23.8M | Buy |
321,271
+89
| +0% | +$6.59K | 1.23% | 25 |
|
|
2022
Q2 | $20.9M | Buy |
321,182
+53,634
| +20% | +$3.5M | 1.08% | 29 |
|
|
2022
Q1 | $16.9M | Buy |
+267,548
| New | +$16.9M | 0.64% | 65 |
|
|
2020
Q3 | – | Sell |
-87,835
| Closed | -$7.87M | – | 344 |
|
|
2020
Q2 | $7.87M | Sell |
87,835
-186,315
| -68% | -$16.7M | 0.34% | 98 |
|
|
2020
Q1 | $27.3M | Buy |
274,150
+25,630
| +10% | +$2.55M | 1.58% | 15 |
|
|
2019
Q4 | $28.6M | Buy |
248,520
+44,880
| +22% | +$5.16M | 1.21% | 21 |
|
|
2019
Q3 | $25.7M | Buy |
203,640
+22,470
| +12% | +$2.83M | 1.2% | 27 |
|
|
2019
Q2 | $21.8M | Buy |
181,170
+24,410
| +16% | +$2.94M | 0.88% | 42 |
|
|
2019
Q1 | $13.7M | Buy |
156,760
+28,153
| +22% | +$2.46M | 0.56% | 70 |
|
|
2018
Q4 | $12.9M | Buy |
+128,607
| New | +$12.9M | 0.63% | 64 |
|